Vir Biotechnology gains 10% after receiving EUA for its COVID-19 treatment

Vir Biotechnology Inc (NASDAQ: VIR) shares jumped roughly 10% in after-hours trading on Wednesday as the company received emergency use authorisation for its COVID-19 drug from the U.S Food and Drug Administration (FDA). The federal agency’s approval for Sotrovimab (VIR-7831) that the biotech firm developed in collaboration with GlaxoSmithKline applies to pediatric patients and high-risk […]